5-HT2C Agonists as Therapeutics for the Treatment of Schizophrenia.

Autor: Rosenzweig-Lipson, Sharon, Comery, Thomas A., Marquis, Karen L., Gross, Jonathan, Dunlop, John
Zdroj: Novel Antischizophrenia Treatments; 2012, p147-165, 19p
Databáze: Complementary Index